Beta-2 Microglobulin (B2M)
|Product Name||Beta-2 Microglobulin|
|Purity||> 98% (SDS-PAGE)|
|Protein||1.0 - 2.0 mg/mL (A280, E0.1%280 nm=1.65)|
|Form||Solution in sodium phosphate, sodium chloride, EDTA, and 0.05% sodium azide, pH 7.2.|
|Appearance||Clear, light straw colored liquid|
|Molecular Weight||Approx. 12,000|
|Gene||B2M, CDABP0092, HDCMA22P|
Lee Biosolutions is the leading producer and supplier of human urine Beta-2 Microglobulin (B2M) for use in medical autoimmune research and manufacturing of clinical diagnostic assays.
Custom preparations, technical support, bulk quantities and aliquoting available, email Info@leebio.com for more details.
Serum beta-2 Microglobulin, an endogenous marker for renal function, has been shown to be an independent predictor of mortality in older adults.
The characteristics of B2M make it useful as a tumor marker for some blood cell cancers, for detecting kidney damage, and for distinguishing between glomerular and tubular disorders of the kidney. It is not diagnostic for a specific disease, but it gives the doctor additional information about someone's likely prognosis and about the health of their kidneys.
Human b-2 Microglobulin (B2MG) is an 11.8 kD protein identical to the light chain of the HLA-A, -B, and –C antigen. B2MG is expressed on nucleated cells, and is found at low levels in the serum and urine of normal individuals. B2MG concentrations are increased in inflammatory diseases, some viral diseases, renal dysfunction, and autoimmune diseases. A number of publications are available which explain the interpretation of serum levels in assessing the status of individuals with various clinical conditions.